Panel Discussion: Treatment options for relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) patients. Can Hematol Today [Internet]. 30 oct. 2022 [cité 21 avr. 2026];1(S10). Disponible à: https://canadianhematologytoday.com/article/view/29